KEGG   PATHWAY: shon05169
Entry
shon05169                   Pathway                                
Name
Epstein-Barr virus infection - Sturnira hondurensis
Description
Epstein-Barr virus (EBV) is a gamma-herpes virus that widely infects human populations predominantly at an early age but remains mostly asymptomatic. EBV has been linked to a wide spectrum of human malignancies, including nasopharyngeal carcinoma and other hematologic cancers, like Hodgkin's lymphoma, Burkitt's lymphoma (BL), B-cell immunoblastic lymphoma in HIV patients, and posttransplant-associated lymphoproliferative diseases.  EBV has the unique ability to establish life-long latent infection in primary human B lymphocytes. During latent infection, EBV expresses a small subset of genes, including 6 nuclear antigens (EBNA-1, -2, -3A, -3B, -3C, and -LP), 3 latent membrane proteins (LMP-1, -2A, and -2B), 2 small noncoding RNAs (EBER-1 and 2). On the basis of these latent gene expression, three different latency patterns associated with the types of cancers are recognized.
Class
Human Diseases; Infectious disease: viral
Pathway map
shon05169  Epstein-Barr virus infection
shon05169

Organism
Sturnira hondurensis [GN:shon]
Gene
118982573  CR2; complement receptor type 2 isoform X1 [KO:K04012]
118981330  LOW QUALITY PROTEIN: HLA class II histocompatibility antigen, DP alpha 1 chain-like [KO:K06752]
118981732  LOW QUALITY PROTEIN: HLA class II histocompatibility antigen, DP alpha 1 chain-like [KO:K06752]
118982809  LOW QUALITY PROTEIN: RLA class II histocompatibility antigen, DP alpha-1 chain-like [KO:K06752]
118999033  DLA class II histocompatibility antigen, DR-1 beta chain-like isoform X1 [KO:K06752]
118999034  HLA class II histocompatibility antigen, DR alpha chain-like [KO:K06752]
118999036  SLA class II histocompatibility antigen, DQ haplotype D alpha chain-like [KO:K06752]
118999037  boLa class II histocompatibility antigen, DQB*0101 beta chain-like isoform X1 [KO:K06752]
118991469  HLA class II histocompatibility antigen, DM beta chain isoform X1 [KO:K06752]
118991472  HLA class II histocompatibility antigen, DM alpha chain isoform X1 [KO:K06752]
118991540  LOW QUALITY PROTEIN: HLA class II histocompatibility antigen, DO beta chain-like [KO:K06752]
118991542  uncharacterized protein LOC118991542 [KO:K06752]
118999195  H-2 class II histocompatibility antigen, I-E beta chain-like [KO:K06752]
118984928  LOW QUALITY PROTEIN: RLA class II histocompatibility antigen, DP alpha-1 chain-like [KO:K06752]
118995387  TLR2; toll-like receptor 2 isoform X1 [KO:K10159]
118997428  IRAK4; interleukin-1 receptor-associated kinase 4 isoform X1 [KO:K04733] [EC:2.7.11.1]
118994306  IRAK1; interleukin-1 receptor-associated kinase 1 isoform X1 [KO:K04730] [EC:2.7.11.1]
118983180  TRAF6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
119002380  TAB1; TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 isoform X1 [KO:K04403]
118978986  TAB2; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 isoform X1 [KO:K04404]
118982270  MAP3K7; mitogen-activated protein kinase kinase kinase 7 isoform X1 [KO:K04427] [EC:2.7.11.25]
118999523  CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
118993207  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
118994325  IKBKG; NF-kappa-B essential modulator isoform X1 [KO:K07210]
118993928  NFKBIA; NF-kappa-B inhibitor alpha [KO:K04734]
118979949  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
118991736  RELA; transcription factor p65 [KO:K04735]
118987585  TNF; tumor necrosis factor isoform X1 [KO:K03156]
118979610  DDX58; antiviral innate immune response receptor RIG-I [KO:K12646] [EC:5.6.2.6]
118990900  MAVS; mitochondrial antiviral-signaling protein [KO:K12648]
118976597  TRAF3; TNF receptor-associated factor 3 isoform X1 [KO:K03174]
118998723  TBK1; serine/threonine-protein kinase TBK1 [KO:K05410] [EC:2.7.11.10]
119001656  IKBKE; inhibitor of nuclear factor kappa-B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]
118982245  IRF7; interferon regulatory factor 7 isoform X1 [KO:K09447]
118997983  interferon alpha-2-like [KO:K05414]
118984066  interferon alpha-4-like [KO:K05414]
118978917  interferon alpha-2-like [KO:K05414]
118997987  interferon beta-2-like [KO:K05415]
118997988  interferon beta-2-like [KO:K05415]
118997989  interferon beta-2-like [KO:K05415]
118997990  interferon beta-2-like [KO:K05415]
119000288  IFNAR1; interferon alpha/beta receptor 1 isoform X1 [KO:K05130]
119000285  IFNAR2; interferon alpha/beta receptor 2 [KO:K05131]
118985040  JAK1; tyrosine-protein kinase JAK1 [KO:K11217] [EC:2.7.10.2]
118985299  STAT1; signal transducer and activator of transcription 1-alpha/beta isoform X1 [KO:K11220]
118975851  STAT2; signal transducer and activator of transcription 2 [KO:K11221]
118980890  IRF9; interferon regulatory factor 9 isoform X1 [KO:K04693]
119001265  EIF2AK2; interferon-induced, double-stranded RNA-activated protein kinase isoform X1 [KO:K16195] [EC:2.7.11.1]
118991120  2'-5'-oligoadenylate synthase 1-like [KO:K14216] [EC:2.7.7.84]
118991332  LOW QUALITY PROTEIN: 2'-5'-oligoadenylate synthase 3-like [KO:K14216] [EC:2.7.7.84]
118977154  2'-5'-oligoadenylate synthase 1-like isoform X1 [KO:K14216] [EC:2.7.7.84]
118990377  CXCL10; C-X-C motif chemokine 10 [KO:K12671]
118985011  C-X-C motif chemokine 10-like [KO:K12671]
118998232  ISG15; ubiquitin-like protein ISG15 [KO:K12159]
118987956  FAS; tumor necrosis factor receptor superfamily member 6 isoform X1 [KO:K04390]
118998399  FADD; FAS-associated death domain protein [KO:K02373]
118985238  CASP8; caspase-8 [KO:K04398] [EC:3.4.22.61]
118995133  BID; BH3-interacting domain death agonist [KO:K04726]
118994170  BCL2L11; bcl-2-like protein 11 isoform X1 [KO:K16341]
118979386  BCL2; apoptosis regulator Bcl-2 [KO:K02161]
118991499  BAK1; bcl-2 homologous antagonist/killer [KO:K14021]
118983604  cytochrome c [KO:K08738]
119001286  cytochrome c-like [KO:K08738]
118985954  cytochrome c-like [KO:K08738]
119002556  APAF1; apoptotic protease-activating factor 1 [KO:K02084]
118986319  CASP9; caspase-9 [KO:K04399] [EC:3.4.22.62]
118993073  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
118995118  uncharacterized protein LOC118995118 [KO:K10784]
118994765  CD3E; T-cell surface glycoprotein CD3 epsilon chain [KO:K06451]
118994762  CD3G; T-cell surface glycoprotein CD3 gamma chain [KO:K06452]
118994764  CD3D; T-cell surface glycoprotein CD3 delta chain isoform X1 [KO:K06450]
118979262  CD247; T-cell surface glycoprotein CD3 zeta chain isoform X1 [KO:K06453]
118994440  PSMC2; 26S proteasome regulatory subunit 7 [KO:K03061]
118976569  PSMC1; 26S proteasome regulatory subunit 4 [KO:K03062]
118988093  PSMC4; 26S proteasome regulatory subunit 6B [KO:K03063]
118992403  PSMC6; 26S proteasome regulatory subunit 10B [KO:K03064]
118974513  PSMC3; 26S proteasome regulatory subunit 6A [KO:K03065]
119003765  PSMC5; 26S proteasome regulatory subunit 8 isoform X1 [KO:K03066]
118974186  PSMD2; 26S proteasome non-ATPase regulatory subunit 2 [KO:K03028]
118999160  PSMD1; 26S proteasome non-ATPase regulatory subunit 1 isoform X1 [KO:K03032]
118978090  PSMD3; 26S proteasome non-ATPase regulatory subunit 3 [KO:K03033]
119003524  PSMD12; 26S proteasome non-ATPase regulatory subunit 12 [KO:K03035]
119003453  PSMD11; 26S proteasome non-ATPase regulatory subunit 11 [KO:K03036]
118983416  PSMD6; 26S proteasome non-ATPase regulatory subunit 6 [KO:K03037]
118983790  PSMD7; 26S proteasome non-ATPase regulatory subunit 7 [KO:K03038]
118974903  PSMD13; 26S proteasome non-ATPase regulatory subunit 13 [KO:K03039]
118985782  PSMD14; 26S proteasome non-ATPase regulatory subunit 14 [KO:K03030]
118976332  PSMD8; 26S proteasome non-ATPase regulatory subunit 8 [KO:K03031]
118996566  ADRM1; proteasomal ubiquitin receptor ADRM1 isoform X1 [KO:K06691]
118987335  SEM1; 26S proteasome complex subunit SEM1 [KO:K10881]
118991465  TAP1; antigen peptide transporter 1 isoform X1 [KO:K05653] [EC:7.4.2.14]
118991466  TAP2; antigen peptide transporter 2 [KO:K05654] [EC:7.4.2.14]
118991490  tapasin isoform X1 [KO:K08058]
118992559  PDIA3; protein disulfide-isomerase A3 [KO:K08056] [EC:5.3.4.1]
118984114  CALR; calreticulin [KO:K08057]
119004008  patr class I histocompatibility antigen, A-2 alpha chain-like isoform X1 [KO:K06751]
118980727  H-2 class I histocompatibility antigen, Q9 alpha chain-like [KO:K06751]
118980772  patr class I histocompatibility antigen, A-126 alpha chain-like [KO:K06751]
118996659  class I histocompatibility antigen, Gogo-B*0102 alpha chain-like isoform X1 [KO:K06751]
118981397  saoe class I histocompatibility antigen, A alpha chain-like [KO:K06751]
118981398  LOW QUALITY PROTEIN: patr class I histocompatibility antigen, A-126 alpha chain-like [KO:K06751]
118981399  HLA class I histocompatibility antigen, alpha chain F-like [KO:K06751]
118981513  H-2 class I histocompatibility antigen, alpha chain-like [KO:K06751]
118981536  HLA class I histocompatibility antigen, alpha chain G-like isoform X1 [KO:K06751]
118981733  popy Class I histocompatibility antigen, A-1 alpha chain-like isoform X1 [KO:K06751]
118981759  patr class I histocompatibility antigen, A-126 alpha chain-like [KO:K06751]
118996962  LOW QUALITY PROTEIN: patr class I histocompatibility antigen, A-126 alpha chain-like [KO:K06751]
118997317  LOW QUALITY PROTEIN: patr class I histocompatibility antigen, A-126 alpha chain-like [KO:K06751]
118997319  patr class I histocompatibility antigen, A-126 alpha chain-like [KO:K06751]
118997469  HLA class I histocompatibility antigen, alpha chain F-like [KO:K06751]
118982113  patr class I histocompatibility antigen, A-2 alpha chain-like isoform X1 [KO:K06751]
118974354  patr class I histocompatibility antigen, A-126 alpha chain-like isoform X1 [KO:K06751]
118974356  HLA class I histocompatibility antigen, alpha chain E-like [KO:K06751]
118974594  popy Class I histocompatibility antigen, A-1 alpha chain-like [KO:K06751]
118982708  popy class I histocompatibility antigen, alpha chain E-like isoform X1 [KO:K06751]
118974887  patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751]
118982813  patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751]
118982835  BOLA class I histocompatibility antigen, alpha chain BL3-7-like [KO:K06751]
118982863  class I histocompatibility antigen, Gogo-B*0201 alpha chain-like [KO:K06751]
118999075  HLA class I histocompatibility antigen, alpha chain G-like [KO:K06751]
118999079  patr class I histocompatibility antigen, A-126 alpha chain-like isoform X1 [KO:K06751]
118999080  HLA class I histocompatibility antigen, alpha chain F-like isoform X1 [KO:K06751]
118983746  BOLA class I histocompatibility antigen, alpha chain BL3-7-like [KO:K06751]
118991392  LOW QUALITY PROTEIN: patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751]
118991570  class I histocompatibility antigen, Gogo-C*0202 alpha chain-like isoform X1 [KO:K06751]
118999324  patr class I histocompatibility antigen, A-126 alpha chain-like [KO:K06751]
118983999  saoe class I histocompatibility antigen, A alpha chain-like isoform X1 [KO:K06751]
118984161  LOW QUALITY PROTEIN: patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751]
118999599  HLA class I histocompatibility antigen, alpha chain G-like [KO:K06751]
118976536  HLA class I histocompatibility antigen, alpha chain G-like [KO:K06751]
118992170  class I histocompatibility antigen, Gogo-C*0202 alpha chain-like [KO:K06751]
118992194  patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751]
118992220  patr class I histocompatibility antigen, A-126 alpha chain-like [KO:K06751]
118977201  saoe class I histocompatibility antigen, A alpha chain-like [KO:K06751]
118977214  patr class I histocompatibility antigen, alpha chain E-like [KO:K06751]
118984919  patr class I histocompatibility antigen, A-108 alpha chain-like [KO:K06751]
118984920  LOW QUALITY PROTEIN: patr class I histocompatibility antigen, A-108 alpha chain-like [KO:K06751]
119000606  saoe class I histocompatibility antigen, A alpha chain-like [KO:K06751]
118977705  HLA class I histocompatibility antigen, alpha chain F-like [KO:K06751]
118993317  popy Class I histocompatibility antigen, A-1 alpha chain-like isoform X1 [KO:K06751]
119001579  saoe class I histocompatibility antigen, A alpha chain-like [KO:K06751]
119001581  patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751]
119002099  HLA class I histocompatibility antigen, B alpha chain-like [KO:K06751]
118978534  class I histocompatibility antigen, Gogo-B*0101 alpha chain-like [KO:K06751]
118978541  HLA class I histocompatibility antigen, alpha chain G-like [KO:K06751]
118978542  patr class I histocompatibility antigen, A-126 alpha chain-like isoform X1 [KO:K06751]
118986505  patr class I histocompatibility antigen, B-2 alpha chain-like [KO:K06751]
118986617  patr class I histocompatibility antigen, B-2 alpha chain-like [KO:K06751]
118994399  popy Class I histocompatibility antigen, A-1 alpha chain-like [KO:K06751]
118986866  popy Class I histocompatibility antigen, A-1 alpha chain-like isoform X1 [KO:K06751]
118987037  patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751]
118987155  patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751]
118987156  saoe class I histocompatibility antigen, A alpha chain-like [KO:K06751]
119002841  class I histocompatibility antigen, Gogo-C*0202 alpha chain-like [KO:K06751]
118979575  LOW QUALITY PROTEIN: saoe class I histocompatibility antigen, A alpha chain-like [KO:K06751]
118995180  HLA class I histocompatibility antigen, alpha chain E-like [KO:K06751]
119003007  uncharacterized protein LOC119003007 [KO:K06751]
118992572  B2M; beta-2-microglobulin [KO:K08055]
118976628  SNW1; SNW domain-containing protein 1 [KO:K06063]
118987735  SIN3A; paired amphipathic helix protein Sin3a [KO:K11644]
118997724  HDAC1; histone deacetylase 1 isoform X1 [KO:K06067] [EC:3.5.1.98]
119000192  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
118991010  NCOR2; nuclear receptor corepressor 2 isoform X1 [KO:K06065]
118984303  SAP30; histone deacetylase complex subunit SAP30 [KO:K19202]
118986121  SAP30L; histone deacetylase complex subunit SAP30L [KO:K19202]
118985690  CIR1; corepressor interacting with RBPJ 1 [KO:K06066]
118985524  RBPJL; recombining binding protein suppressor of hairless-like protein isoform X1 [KO:K06053]
118985975  RBPJ; recombining binding protein suppressor of hairless isoform X1 [KO:K06053]
118982930  HES1; transcription factor HES-1 [KO:K06054]
118987697  FCER2; low affinity immunoglobulin epsilon Fc receptor isoform X1 [KO:K06468]
118977790  RUNX3; runt-related transcription factor 3 [KO:K09279]
118988677  MYC; myc proto-oncogene protein isoform X1 [KO:K04377]
118992721  ubiquitin carboxyl-terminal hydrolase 7-like [KO:K11838] [EC:3.4.19.12]
118992723  ubiquitin carboxyl-terminal hydrolase 7 [KO:K11838] [EC:3.4.19.12]
118989366  MDM2; E3 ubiquitin-protein ligase Mdm2 isoform X1 [KO:K06643] [EC:2.3.2.27]
118974748  TP53; cellular tumor antigen p53 [KO:K04451]
118998962  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
118984458  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
118984673  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
118978970  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
118974481  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
118977345  POLK; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
119004242  TRAF5; TNF receptor-associated factor 5 isoform X1 [KO:K09849]
118997522  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
118986375  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
118995662  phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
118982454  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
118975178  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
118998595  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
118988441  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
119003271  AKT3; RAC-gamma serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
118988089  AKT2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
119001650  MAP3K14; mitogen-activated protein kinase kinase kinase 14 isoform X1 [KO:K04466] [EC:2.7.11.25]
118995331  RELB; transcription factor RelB isoform X1 [KO:K09253]
118999475  NFKB2; nuclear factor NF-kappa-B p100 subunit isoform X1 [KO:K04469]
118983883  TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein isoform X1 [KO:K03171]
118976327  NFKBIB; NF-kappa-B inhibitor beta [KO:K02581]
118992175  NFKBIE; NF-kappa-B inhibitor epsilon isoform X1 [KO:K05872]
118974732  MAP2K4; dual specificity mitogen-activated protein kinase kinase 4 isoform X1 [KO:K04430] [EC:2.7.12.2]
118994072  MAP2K7; dual specificity mitogen-activated protein kinase kinase 7 isoform X1 [KO:K04431] [EC:2.7.12.2]
118976281  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
118994117  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
118995102  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
118980132  TRAF2; TNF receptor-associated factor 2 [KO:K03173] [EC:2.3.2.27]
118986453  RIPK1; receptor-interacting serine/threonine-protein kinase 1 isoform X1 [KO:K02861] [EC:2.7.11.1]
119002731  MAP2K3; dual specificity mitogen-activated protein kinase kinase 3 isoform X1 [KO:K04432] [EC:2.7.12.2]
119003578  MAP2K6; dual specificity mitogen-activated protein kinase kinase 6 isoform X1 [KO:K04433] [EC:2.7.12.2]
118988883  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
118988898  MAPK11; mitogen-activated protein kinase 11 isoform X1 [KO:K04441] [EC:2.7.11.24]
118998971  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
118998973  MAPK14; mitogen-activated protein kinase 14 isoform X1 [KO:K04441] [EC:2.7.11.24]
118984936  JUN; transcription factor AP-1 [KO:K04448]
118980251  ENTPD8; ectonucleoside triphosphate diphosphohydrolase 8 isoform X1 [KO:K01510] [EC:3.6.1.5]
118990299  ENTPD1; ectonucleoside triphosphate diphosphohydrolase 1 isoform X1 [KO:K01510] [EC:3.6.1.5]
118976189  ENTPD3; ectonucleoside triphosphate diphosphohydrolase 3 [KO:K01510] [EC:3.6.1.5]
118985558  CD40; tumor necrosis factor receptor superfamily member 5 isoform X1 [KO:K03160]
118983169  CD44; CD44 antigen isoform X1 [KO:K06256]
118997404  ITGAL; integrin alpha-L isoform X1 [KO:K05718]
118981973  CD58; lymphocyte function-associated antigen 3 [KO:K06492]
118997141  VIM; vimentin [KO:K07606]
118986669  TNFAIP3; tumor necrosis factor alpha-induced protein 3 isoform X1 [KO:K11859] [EC:3.4.19.12]
118975019  JAK3; tyrosine-protein kinase JAK3 [KO:K11218] [EC:2.7.10.2]
118978208  STAT3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
118974987  LYN; tyrosine-protein kinase Lyn isoform X1 [KO:K05854] [EC:2.7.10.2]
118983557  SYK; tyrosine-protein kinase SYK isoform X1 [KO:K05855] [EC:2.7.10.2]
118992244  NEDD4; E3 ubiquitin-protein ligase NEDD4 isoform X1 [KO:K10591] [EC:2.3.2.26]
118995001  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
118996677  BTK; tyrosine-protein kinase BTK [KO:K07370] [EC:2.7.10.2]
118990295  BLNK; B-cell linker protein [KO:K07371]
118983037  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1 [KO:K05859] [EC:3.1.4.11]
118998776  SKP2; S-phase kinase-associated protein 2 isoform X1 [KO:K03875]
118978371  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
118998396  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
118999952  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
118991404  CCND3; G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
118975891  CDK4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
119000945  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
118974983  LOW QUALITY PROTEIN: cyclin-A2-like [KO:K06627]
118994860  CCNA1; cyclin-A1 [KO:K06627]
118995492  CCNA2; cyclin-A2 [KO:K06627]
119001171  CCNE1; G1/S-specific cyclin-E1 [KO:K06626]
118995572  CCNE2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
118975970  CDK2; cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
118983966  RB1; retinoblastoma-associated protein isoform X1 [KO:K06618]
118985966  E2F1; transcription factor E2F1 [KO:K17454]
118977797  E2F2; transcription factor E2F2 [KO:K09389]
118981164  E2F3; transcription factor E2F3 isoform X1 [KO:K06620]
Compound
C00076  Calcium cation
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Young LS, Rickinson AB.
  Title
Epstein-Barr virus: 40 years on.
  Journal
Nat Rev Cancer 4:757-68 (2004)
DOI:10.1038/nrc1452
Reference
  Authors
Saha A, Robertson ES
  Title
Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.
  Journal
Clin Cancer Res 17:3056-63 (2011)
DOI:10.1158/1078-0432.CCR-10-2578
Reference
  Authors
Ning S
  Title
Innate immune modulation in EBV infection.
  Journal
Herpesviridae 2:1 (2011)
DOI:10.1186/2042-4280-2-1
Reference
  Authors
Stanfield BA, Luftig MA
  Title
Recent advances in understanding Epstein-Barr virus.
  Journal
F1000Res 6:386 (2017)
DOI:10.12688/f1000research.10591.1
Reference
  Authors
van Gent M, Braem SG, de Jong A, Delagic N, Peeters JG, Boer IG, Moynagh PN, Kremmer E, Wiertz EJ, Ovaa H, Griffin BD, Ressing ME
  Title
Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling.
  Journal
PLoS Pathog 10:e1003960 (2014)
DOI:10.1371/journal.ppat.1003960
Reference
  Authors
Rajsbaum R, Garcia-Sastre A
  Title
Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways.
  Journal
Trends Microbiol 21:421-9 (2013)
DOI:10.1016/j.tim.2013.06.006
Reference
  Authors
Hoffmann HH, Schneider WM, Rice CM
  Title
Interferons and viruses: an evolutionary arms race of molecular interactions.
  Journal
Trends Immunol 36:124-38 (2015)
DOI:10.1016/j.it.2015.01.004
Reference
  Authors
Spender LC, Inman GJ
  Title
Inhibition of germinal centre apoptotic programmes by epstein-barr virus.
  Journal
Adv Hematol 2011:829525 (2011)
DOI:10.1155/2011/829525
Reference
  Authors
Fu Q, He C, Mao ZR
  Title
Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells.
  Journal
J Zhejiang Univ Sci B 14:8-24 (2013)
DOI:10.1631/jzus.B1200189
Reference
  Authors
Wang Y, Banerjee S, Ding L, Cai C, Wei F, Cai Q
  Title
The regulatory role of protein phosphorylation in human gammaherpesvirus associated cancers.
  Journal
Virol Sin 32:357-368 (2017)
DOI:10.1007/s12250-017-4081-9
Reference
  Authors
Melchjorsen J
  Title
Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.
  Journal
Viruses 5:470-527 (2013)
DOI:10.3390/v5020470
Reference
  Authors
Hansen TH, Bouvier M
  Title
MHC class I antigen presentation: learning from viral evasion strategies.
  Journal
Nat Rev Immunol 9:503-13 (2009)
DOI:10.1038/nri2575
Reference
  Authors
Ressing ME, Horst D, Griffin BD, Tellam J, Zuo J, Khanna R, Rowe M, Wiertz EJ
  Title
Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
  Journal
Semin Cancer Biol 18:397-408 (2008)
DOI:10.1016/j.semcancer.2008.10.008
Reference
  Authors
Horst D, Verweij MC, Davison AJ, Ressing ME, Wiertz EJ
  Title
Viral evasion of T cell immunity: ancient mechanisms offering new applications.
  Journal
Curr Opin Immunol 23:96-103 (2011)
DOI:10.1016/j.coi.2010.11.005
Reference
  Authors
Ghosh Roy S, Robertson ES, Saha A
  Title
Epigenetic Impact on EBV Associated B-Cell Lymphomagenesis.
  Journal
Biomolecules 6:E46 (2016)
DOI:10.3390/biom6040046
Reference
  Authors
Dawson CW, Port RJ, Young LS
  Title
The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC).
  Journal
Semin Cancer Biol 22:144-53 (2012)
DOI:10.1016/j.semcancer.2012.01.004
Reference
  Authors
Cai Q, Chen K, Young KH
  Title
Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.
  Journal
Exp Mol Med 47:e133 (2015)
DOI:10.1038/emm.2014.105
Reference
  Authors
Zheng H, Li LL, Hu DS, Deng XY, Cao Y
  Title
Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
  Journal
Cell Mol Immunol 4:185-96 (2007)
Reference
  Authors
Ersing I, Bernhardt K, Gewurz BE
  Title
NF-kappaB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1.
  Journal
Viruses 5:1587-606 (2013)
DOI:10.3390/v5061587
Reference
  Authors
Wang LW, Jiang S, Gewurz BE
  Title
Epstein-Barr Virus LMP1-Mediated Oncogenicity.
  Journal
J Virol 91:e01718-16 (2017)
DOI:10.1128/JVI.01718-16
Reference
  Authors
Mori N, Morishita M, Tsukazaki T, Yamamoto N
  Title
Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
  Journal
Int J Cancer 105:661-8 (2003)
DOI:10.1002/ijc.11146
Reference
  Authors
Edwards RH, Marquitz AR, Raab-Traub N
  Title
Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.
  Journal
MBio 6:e00441-15 (2015)
DOI:10.1128/mBio.00441-15
Reference
  Authors
Thorley-Lawson DA
  Title
Epstein-Barr virus: exploiting the immune system.
  Journal
Nat Rev Immunol 1:75-82 (2001)
DOI:10.1038/35095584
Reference
  Authors
Eliopoulos AG, Young LS
  Title
LMP1 structure and signal transduction.
  Journal
Semin Cancer Biol 11:435-44 (2001)
DOI:10.1006/scbi.2001.0410
Reference
  Authors
Holowaty MN, Sheng Y, Nguyen T, Arrowsmith C, Frappier L
  Title
Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP.
  Journal
J Biol Chem 278:47753-61 (2003)
DOI:10.1074/jbc.M307200200
Reference
  Authors
Kang H, Kiess A, Chung CH
  Title
Emerging biomarkers in head and neck cancer in the era of genomics.
  Journal
Nat Rev Clin Oncol 12:11-26 (2015)
DOI:10.1038/nrclinonc.2014.192
Reference
  Authors
Tornesello ML, Annunziata C, Tornesello AL, Buonaguro L, Buonaguro FM
  Title
Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers.
  Journal
Cancers (Basel) 10:E213 (2018)
DOI:10.3390/cancers10070213
Reference
  Authors
Sato Y, Kamura T, Shirata N, Murata T, Kudoh A, Iwahori S, Nakayama S, Isomura H, Nishiyama Y, Tsurumi T
  Title
Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex.
  Journal
PLoS Pathog 5:e1000530 (2009)
DOI:10.1371/journal.ppat.1000530
Reference
  Authors
Saha A, Murakami M, Kumar P, Bajaj B, Sims K, Robertson ES
  Title
Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.
  Journal
J Virol 83:4652-69 (2009)
DOI:10.1128/JVI.02408-08
Reference
  Authors
Yi F, Saha A, Murakami M, Kumar P, Knight JS, Cai Q, Choudhuri T, Robertson ES
  Title
Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.
  Journal
Virology 388:236-47 (2009)
DOI:10.1016/j.virol.2009.03.027
Reference
  Authors
Kumar P, Murakami M, Kaul R, Saha A, Cai Q, Robertson ES
  Title
Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C.
  Journal
Future Virol 4:79-91 (2009)
DOI:10.2217/17460794.4.1.79
Reference
  Authors
Longnecker R
  Title
Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
  Journal
Adv Cancer Res 79:175-200 (2000)
DOI:10.1016/s0065-230x(00)79006-3
Reference
  Authors
El-Sharkawy A, Al Zaidan L, Malki A
  Title
Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis.
  Journal
Front Oncol 8:265 (2018)
DOI:10.3389/fonc.2018.00265
Reference
  Authors
Dolcetti R, Masucci MG
  Title
Epstein-Barr virus: induction and control of cell transformation.
  Journal
J Cell Physiol 196:207-18 (2003)
DOI:10.1002/jcp.10263
Reference
  Authors
Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, Murakami M, Cai Q, Robertson ES
  Title
Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.
  Journal
PLoS Pathog 7:e1001275 (2011)
DOI:10.1371/journal.ppat.1001275
Related
pathway
shon03050  Proteasome
shon04010  MAPK signaling pathway
shon04020  Calcium signaling pathway
shon04064  NF-kappa B signaling pathway
shon04110  Cell cycle
shon04115  p53 signaling pathway
shon04210  Apoptosis
shon04612  Antigen processing and presentation
shon04620  Toll-like receptor signaling pathway
shon04622  RIG-I-like receptor signaling pathway
shon04630  JAK-STAT signaling pathway
shon04662  B cell receptor signaling pathway
KO pathway
ko05169   
LinkDB

DBGET integrated database retrieval system